Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic value of complement serum C3 level and glomerular C3 deposits in anti-glomerular basement membrane disease.
Caillard P, Vigneau C, Halimi JM, Hazzan M, Thervet E, Heitz M, Juillard L, Audard V, Rabant M, Hertig A, Subra JF, Vuiblet V, Guerrot D, Tamain M, Essig M, Lobbedez T, Quemeneur T, Legendre M, Ganea A, Peraldi MN, Vrtovsnik F, Daroux M, Makdassi R, Choukroun G, Titeca-Beauport D. Caillard P, et al. Among authors: daroux m. Front Immunol. 2023 Jul 5;14:1190394. doi: 10.3389/fimmu.2023.1190394. eCollection 2023. Front Immunol. 2023. PMID: 37475859 Free PMC article.
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy.
Barratt J, Lafayette R, Kristensen J, Stone A, Cattran D, Floege J, Tesar V, Trimarchi H, Zhang H, Eren N, Paliege A, Rovin BH; NefIgArd Trial Investigators. Barratt J, et al. Kidney Int. 2023 Feb;103(2):391-402. doi: 10.1016/j.kint.2022.09.017. Epub 2022 Oct 19. Kidney Int. 2023. PMID: 36270561 Free article. Clinical Trial.
Early Renal Recovery after the First Flare of Pauci-Immune Glomerulonephritis.
Zaworski J, Gnemmi V, Bataille P, Hachulla E, Glowacki F, Gibier JB, Daroux M, Ratsimbazafy A, Bitton L, Humez S, Guincestre T, Béhal H, Azar R, Hoffmann M, Cardon G, Bourdon F, Lemoine C, Auxenfant E, Copin MC, Vandenbussche C, Quéméneur T; pour la cohorte RENVAS. Zaworski J, et al. Among authors: daroux m. Am J Nephrol. 2022;53(1):59-68. doi: 10.1159/000520285. Epub 2022 Jan 17. Am J Nephrol. 2022. PMID: 35038711
Severe Infection in Anti-Glomerular Basement Membrane Disease: A Retrospective Multicenter French Study.
Caillard P, Vigneau C, Halimi JM, Hazzan M, Thervet E, Heitz M, Juillard L, Audard V, Rabant M, Hertig A, Subra JF, Vuiblet V, Guerrot D, Tamain M, Essig M, Lobbedez T, Quemeneur T, Rebibou JM, Ganea A, Peraldi MN, Vrtovsnik F, Daroux M, Lamrani A, Makdassi R, Choukroun G, Titeca-Beauport D. Caillard P, et al. Among authors: daroux m. J Clin Med. 2020 Mar 4;9(3):698. doi: 10.3390/jcm9030698. J Clin Med. 2020. PMID: 32143501 Free PMC article.
[Kidney disease care for the elderly].
Hamroun A, Frimat M, Beuscart JB, Buob D, Lionet A, Lebas C, Daroux M, Provôt F, Hazzan M, Boulanger É, Glowacki F. Hamroun A, et al. Among authors: daroux m. Nephrol Ther. 2019 Dec;15(7):533-552. doi: 10.1016/j.nephro.2019.10.001. Epub 2019 Nov 9. Nephrol Ther. 2019. PMID: 31711751 Review. French.
Knockout of receptor for advanced glycation end-products attenuates age-related renal lesions.
Teissier T, Quersin V, Gnemmi V, Daroux M, Howsam M, Delguste F, Lemoine C, Fradin C, Schmidt AM, Cauffiez C, Brousseau T, Glowacki F, Tessier FJ, Boulanger E, Frimat M. Teissier T, et al. Among authors: daroux m. Aging Cell. 2019 Apr;18(2):e12850. doi: 10.1111/acel.12850. Epub 2019 Feb 22. Aging Cell. 2019. PMID: 30794349 Free PMC article.
23 results